18086-25-4

166090-00-2 Carbonic acid, dimethylester, polymer with a-hydro-w-hydroxypoly(oxy-1,2-ethanediyl),ether with polyethylene glycol monodecyl ether

16608-68-7 2-Butene, 3-chloro-1-phenyl-, (Z)-

89053-40-7 2H-Pyrrol-2-one,5-[(2,6-dimethylphenyl)methylene]-1,5-dihydro-3,4-dimethyl-, (Z)-

180889-34-3 METHANIMIDAMIDE,N-(1,2-DIHYDROXYETHYL)-N,N-DIMETHYL-,[R-(E)]-

166090-01-3 Butanedioic acid,monopolyisobutylene derivs., compds. with 1-(dimethylamino)-2-propanol (1:2)

89053-47-4 4-Oxazolidinone, 3-methyl-5-(2-methylpropyl)-, (S)-

195711-95-6 Carbamic acid, [4-[(3-amino-2-chloro-4-quinolinyl)amino]butyl]-,1,1-dimethylethyl ester

166089-32-3 Lintuzumab

18089-32-2 (20R)-11β,17-Dihydroxy-20,21-[isopropylidenebisoxy]pregna-1,4-dien-3-one

166094-02-6 (S)-2-TERT-BUTOXYCARBONYLAMINO-PENT-3-ENOIC ACID ETHYL ESTER

166092-91-7 8-AMINO-DG CEP

180894-18-2 L-Serine, N-[N-[bis(1-methylethoxy)phosphinyl]-L-histidyl]-

180894-78-4 Octadecanoic acid,(1S)-1-[[(4-methoxyphenyl)methoxy]methyl]-2-[[1-oxo-6-[[(phenylmethoxy)carbonyl]amino]hexyl]oxy]ethyl ester

89053-52-1 4-Oxazolidinone, 2,2,3-trimethyl-5-(1-methylethyl)-, (S)-

89053-59-8 1,3-Dioxolan-4-one, 5-(1-methylethyl)-, (S)-

166089-99-2 Formaldehyde, polymers with bisphenol A, 2-(diethylamino)ethanol, melamine and melamine 2-(2-hydroxyethoxy)ethyl derivs.

89053-53-2 4-Oxazolidinone, 2,2-dimethyl-5-(2-methylpropyl)-, (S)-

180895-43-6 HYDRAZINECARBOXYLIC ACID 2-(TRIFLUOROACETYL)-,METHYL ESTER

166090-74-0 H-ASP-ALA-GLU-PHE-ARG-HIS-ASP-SER-GLY-TYR-GLU-VAL-HIS-HIS-GLN-LYS-LEU-VAL-PHE-PHE-ALA-GLU-ASP-VAL-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-LEU-MET-VAL-GLY-GLY-VAL-VAL-ILE-ALA-OH

16607-58-2 3-(dimethylamino)-4,6-diphenylpyridin-2(1H)-one